Stem cells may battle a form of blindness

A therapy derived from human embryonic stem cells may help millions of Americans battle a common form of blindness.

Advanced Cell Technology Inc. said Monday that it has received a green light from the U.S. Food and Drug Administration to begin a clinical trial to test its therapeutic cells as a treatment for dry age-related macular degeneration, according to a story in the Chicago Tribune.

The company plans to enroll a dozen patients in a Phase I/II trial, which would primarily test the safety of the cells and whether they are well-tolerated by patients.

Age-related macular degeneration is a disease in which the macula – in the middle of the retina in the back of the eye – is gradually destroyed.

In the dry version of AMD, objects in the center of a patient’s visual field become blurry and they have trouble recognizing faces, according to the National Eye Institute.

Though there are treatments that may stall the progression of dry AMD, there is no cure. An estimated 10 million to 15 million Americans suffer from dry AMD, and that number is expected to rise as the population ages.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s